GUYER DAVID R — SEC Form 4 filings
SEC reporting owner CIK 1277476. 4 Form 4 filings on record with FilingPulse; latest filed 2024-07-16.
Transaction summary — filings shown
Covers all 4 filings on record, filed 2024-01-09 to 2024-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 34,875 shares, $383,745 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 11,625 shares @ $12.65 ($147,045) in EyePoint Pharmaceuticals, Inc., filed 2024-05-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| EyePoint Pharmaceuticals, Inc. (EYPT) | Director | 4 | — | 3 legs · 34,875 sh · $383,745 | 13 |
Form 4 filings — GUYER DAVID R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2024-07-16 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 3,250 @ $3.50 · Option exercise (M): 6,525 @ $3.26 · Sale (S): 11,625 @ $10.06 · Option exercise (M): 3,250 (derivative) @ $0 · Option exercise (M): 6,525 (derivative) @ $0 | EDGAR |
| 2024-06-04 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 6,525 @ $3.26 · Option exercise (M): 3,250 @ $3.50 · Sale (S): 11,625 @ $10.30 · Option exercise (M): 3,250 (derivative) @ $0 · Option exercise (M): 6,525 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Option exercise (M): 6,525 @ $3.26 · Option exercise (M): 3,250 @ $3.50 · Sale (S): 11,625 @ $12.65 · Option exercise (M): 3,250 (derivative) @ $0 · Option exercise (M): 6,525 (derivative) @ $0 | EDGAR |
| 2024-01-09 | 4 | EyePoint Pharmaceuticals, Inc. (EYPT) | Grant/award (A): 25,014 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1277476 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →